Document Detail


Interferon Stimulated Genes and Hepatitis C Virus Infection.
MedLine Citation:
PMID:  23151203     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Hepatitis C Virus (HCV) is a major cause of chronic liver disease worldwide. In addition to viral and environmental behavioral factors, host genetic diversity is believed to contribute to the spectrum of the disease. The sequencing of the human genome, together with the development of high-throughput technologies that measure the function of the genome, have afforded unique opportunities to develop profiles that can distinguish and classify discrete subsets of a disease and predict a response to therapy. In 2011, 2 directly acting antivirals (DAAs) have been approved for chronic HCV genotype 1 infection, Telaprevir and Boceprevir, and open a new area for HCV therapy. These 2 NS3/4 protease inhibitors are given in combination with pegylated interferon and ribavirin. Several DAAs are in development. Since a significant number of patients will fail to respond to treatment, or will have significant side effects, it is of major interest to predict a response to treatment as early as possible. Several studies are ongoing to identify biomarkers that could predict treatment outcome in patients with hepatitis C before treatment. Many of the genes upregulated in the liver between nonresponders and responders codes molecules secreted in the serum and can constitute a logical functional approach for the development of serum markers predictors of response to treatment. In the next future, further studies have several challenges to fight. First, large prospective cohorts with well phenotyped patients and appropriate tissue controls are needed. For response to treatment, the appropriate definition of sustained response and the same treatment regimen have to be addressed. Furthermore, improved technology and analytical procedures and the use of large numbers of patients for validation are needed.
Authors:
Tarik Asselah
Related Documents :
15810133 - Canada: study provides further evidence of risk of hepatitis c and hiv transmission in ...
20502073 - A review of hiv in prisons in nepal.
1180053 - Karyometry of liver biopsies in virus hepatitis.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-14
Journal Detail:
Title:  Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research     Volume:  -     ISSN:  1557-7465     ISO Abbreviation:  J. Interferon Cytokine Res.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9507088     Medline TA:  J Interferon Cytokine Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1 INSERM, UMR773, Team "Viral hepatitis", Centre de Recherche Bichat Beaujon , Paris, France .
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Stereoselective Cascade Double-Annulations Provide Diversely Ring-Fused Tetracyclic Benzopyrones.
Next Document:  Injectable Hydrogels from Segmented PEG-bisurea-Copolymers.